GSA Capital Partners LLP Raises Holdings in Cardinal Health, Inc. (NYSE:CAH)

GSA Capital Partners LLP grew its holdings in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 87.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 25,506 shares of the company's stock after acquiring an additional 11,883 shares during the quarter. GSA Capital Partners LLP's holdings in Cardinal Health were worth $2,819,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Williams Jones Wealth Management LLC. acquired a new stake in shares of Cardinal Health during the first quarter worth about $232,000. Avantax Advisory Services Inc. lifted its holdings in shares of Cardinal Health by 23.2% during the first quarter. Avantax Advisory Services Inc. now owns 20,061 shares of the company's stock worth $2,245,000 after purchasing an additional 3,773 shares during the period. Entropy Technologies LP acquired a new stake in shares of Cardinal Health during the first quarter worth about $917,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its holdings in shares of Cardinal Health by 1.7% during the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 393,350 shares of the company's stock worth $44,016,000 after purchasing an additional 6,752 shares during the period. Finally, Eagle Bay Advisors LLC lifted its holdings in shares of Cardinal Health by 48.4% during the first quarter. Eagle Bay Advisors LLC now owns 944 shares of the company's stock worth $106,000 after purchasing an additional 308 shares during the period. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Trading Up 1.5 %

NYSE CAH traded up $1.88 on Tuesday, reaching $123.52. 3,262,258 shares of the company were exchanged, compared to its average volume of 2,095,121. The business's fifty day moving average price is $112.40 and its 200 day moving average price is $104.67. The stock has a market capitalization of $29.89 billion, a P/E ratio of 23.67, a price-to-earnings-growth ratio of 1.50 and a beta of 0.60. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $125.41.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings data on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. The company had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm's revenue for the quarter was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.73 earnings per share. Equities research analysts forecast that Cardinal Health, Inc. will post 7.83 earnings per share for the current year.

Cardinal Health Cuts Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be paid a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date is Thursday, January 2nd. Cardinal Health's dividend payout ratio (DPR) is currently 39.30%.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. Evercore ISI lifted their price target on Cardinal Health from $105.00 to $115.00 and gave the company an "in-line" rating in a research report on Thursday, August 15th. Robert W. Baird lifted their price target on Cardinal Health from $130.00 to $137.00 and gave the company an "outperform" rating in a research report on Thursday, August 15th. JPMorgan Chase & Co. lifted their price target on Cardinal Health from $111.00 to $123.00 and gave the company a "neutral" rating in a research report on Wednesday, August 21st. Argus lifted their price target on Cardinal Health from $115.00 to $125.00 and gave the company a "buy" rating in a research report on Wednesday, September 11th. Finally, Wells Fargo & Company boosted their price objective on Cardinal Health from $95.00 to $101.00 and gave the company an "underweight" rating in a research report on Thursday, August 15th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the company. According to MarketBeat, Cardinal Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $123.00.

Insiders Place Their Bets

In other news, insider Jessica L. Mayer sold 17,896 shares of the company's stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $106.48, for a total value of $1,905,566.08. Following the transaction, the insider now owns 94,529 shares of the company's stock, valued at $10,065,447.92. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, insider Michelle D. Greene sold 4,000 shares of the business's stock in a transaction on Monday, August 19th. The stock was sold at an average price of $108.85, for a total value of $435,400.00. Following the sale, the insider now owns 19,242 shares in the company, valued at approximately $2,094,491.70. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jessica L. Mayer sold 17,896 shares of the business's stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total value of $1,905,566.08. Following the completion of the sale, the insider now owns 94,529 shares in the company, valued at $10,065,447.92. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 113,963 shares of company stock valued at $12,379,980. Insiders own 0.09% of the company's stock.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.